“DAPAGLIFLOZIN: NEWER MOLECULE FOR TREATMENT OF TYPE 2 DIABETES MELLITUSType 2 Diabetes Mellitus Is a Common Chronic Disease That Causes Significant Morbidity and Mortality Worldwide. Diabetes Results from a Combination of Increased Hepatic Glucose Product”. 2024. International Research Journal of Pharmacy 2 (1): 32-40. https://irjponline.org/index.php/irjp/article/view/1741.